Market Research Logo

Europe Antidepressants Drugs, Devices And Therapies Market Forecast 2019-2027

Europe Antidepressants Drugs, Devices And Therapies Market Forecast 2019-2027

KEY FINDINGS

The antidepressants drugs, devices and therapies market in Europe is undergoing an intensified growth of 1.77% CAGR during the forecasting years of 2019-2027. The rising population of depression has given an opportunity for the market in Europe to innovate the drug and therapies with the reduced side effects and greater efficacy along with accelerating the prevalence of depression disorder.

MARKET INSIGHTS

Germany, the United Kingdom, France, Spain, Italy, Russia and the remaining countries forming the Rest of Europe are considered for this market study. For treat depression cases which are growing globally, the demand for antidepressant drugs are also increasing and thus, improving the sales of antidepressant drugs worldwide. Moreover, research and development activities in the global drugs market is expected to discover new, cost-effective and impactful antidepressants in the future, thereby making the bargaining power of buyers as moderate.

COMPETITIVE INSIGHTS

The companies operating in the region are Eli Lilly and Company, Abbot Laboratories, Allergan PLC, Pfizer, Neuronetics, Mayo Clinic, H. Lundbeck AS, Brainsway, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd. and GlaxoSmithKline.


1. Research Scope
1.1. Study Goals 1.2. Scope Of The Market Study 1.3. Who Will Find This Report Useful? 1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data 2.1.1. Secondary Data 2.1.2. Primary Data 2.2. Top-down Approach 2.3. Bottom-up Approach 2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary 3.2. Key Findings 3.2.1. Serotonin And Norepinephrine Reuptake Inhibitors (Snris) Is The Dominant Drug In Antidepressants Market3.2.2. Deep Brain Stimulator Is Expected To Grow Fast Among Other Devices Over The Forecast Period 3.2.3. Cognitive Behavior Therapy (Cbt) Is The Largest Contributor To The Antidepressants Therapies Market
4. Market Dynamics
4.1. Market Definition & Scope 4.2. Market Drivers 4.2.1. Rise In The Number Of Depression Patients 4.2.2. Increase In Aging Population 4.2.3. Rising Consciousness Of Depression As A Medical Disorder 4.2.4. Surge In Sales Of Antidepressants 4.3. Market Restraints 4.3.1. High Cost Of Depression Therapy 4.3.2. Patent Expiration Faced By The Companies 4.3.3. Delay In Product Launches 4.4. Market Opportunities 4.4.1. Huge Market Potential 4.4.2. More Preference For Personnel Therapy & Device Treatment 4.5. Market Challenges 4.5.1. Stiff Competition From The Generic Drugmakers
5. Market By Antidepressants Drugs
5.1. Serotonin And Norepinephrine Reuptake Inhibitors (Snris)5.2. Tricyclic Antidepressants (Tca) 5.3. Monoamine Oxidase Inhibitors (Maois) 5.4. Atypical Antidepressants 5.5. Selective Serotonin Reuptake Inhibitors 5.6. Benzodiazepines 5.7. Anticonvulsants 5.8. Beta-blockers 5.9. Other Antidepressants Drugs
6. Market By Devices
6.1. Deep Brain Stimulators 6.2. Fisher Wallace Stimulators 6.3. Transcranial Magnetic Stimulator 6.4. Other Devices
7. Market By Therapies
7.1. Cognitive Behavior Therapy (Cbt) 7.2. Electroconvulsive Therapy (Ect) 7.3. Rational Emotive Behavior Therapy (Rebt) 7.4. Other Therapies
8. Key Analytics
8.1. Porter’s Five Force Model 8.1.1. Threat Of New Entrants 8.1.2. Threat Of Substitute 8.1.3. Bargaining Power Of Suppliers 8.1.4. Bargaining Power Of Buyers 8.1.5. Threat Of Competitive Rivalry 8.2. Opportunity Matrix 8.3. Vendor Landscape 8.4. Value Chain Analysis 8.4.1. For Drugs 8.4.2. For Devices 8.5. Key Buying Criteria
9. Geographical Analysis
9.1. Europe 9.1.1. Germany 9.1.2. United Kingdom 9.1.3. France 9.1.4. Spain 9.1.5. Italy 9.1.6. Russia 9.1.7. Roe (Rest Of Europe)
10. Competitive Landscape
10.1. Market Share Analysis10.2. Company Profile 10.2.1. Abbot Laboratories 10.2.2. Allergan Plc 10.2.3. Boehringer Ingelheim Gmbh 10.2.4. Brainsway 10.2.5. Eli Lilly And Company 10.2.6. F. Hoffmann-la Roche Ltd. 10.2.7. Glaxosmithkline 10.2.8. H. Lundbeck As 10.2.9. Mayo Clinic 10.2.10. Neuronetics 10.2.11. Pfizer
List Of Tables
Table 1 Europe Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027, (In $ Million) Table 2 Europe Antidepressants Drugs, Devices And Therapies Market, By Antidepressants Drugs, 2019-2027, (In $ Million) Table 3 Europe Antidepressants Drugs, Devices And Therapies Market, By Devices, 2019-2027, (In $ Million) Table 4 Europe Antidepressants Drugs, Devices And Therapies Market, By Therapies, 2019-2027, (In $ Million) Table 5 Opportunity Matrix Table 6 Vendor Landscape Table 7 Europe Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027 (In $ Million)
List Of Figures
Figure 1 Europe Antidepressants Drugs, Devices And Therapies Market Share, By Drugs 2018 & 2027 (%) Figure 2 Snris Market, 2019 - 2027 (In $ Million) Figure 3 Deep Brain Stimulators Market, 2019 - 2027 (In $ Million) Figure 4 Cognitive Behavior Therapy (Cbt) Market ($ Million) Figure 5 Europe Antidepressants Drugs, Devices And Therapies Market, By Cognitive Behavior Therapy (Cbt), 2019-2027, (In $ Million) Figure 6 Europe Antidepressants Drugs, Devices And Therapies Market, By Electroconvulsive Therapy (Ect), 2019-2027, (In $ Million) Figure 7 Europe Antidepressants Drugs, Devices And Therapies Market, By Rational Emotive Behavior Therapy (Rebt), 2019-2027, (In $ Million) Figure 8 Europe Antidepressants Drugs, Devices And Therapies Market, Other Therapies, 2019-2027, (In $ Million) Figure 9 Porter’s Five Force Model Figure 10 Value Chain Of Antidepressant Drugs Figure 11 Value Chain Analysis For Device Market Figure 12 Europe Antidepressants Drugs, Devices And Therapies Market, Regional Outlook, 2018 & 2027, (%) Figure 13 Germany Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 14 United Kingdom Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 15 France Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 16 Spain Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 17 Italy Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 18 Russia Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 19 Roe Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 20 Market Share Of Antidepressants Drug Manufacturers (Percentage Of Sales), 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report